Phase I study of oral vinorelbine in combination with erlotinib in advanced non-small cell lung cancer (NSCLC) using two different schedules

由 Sutiman N., Zhang Z., Ang M.K., Tan S.-W.D., Toh C.K., Ng Q.S., Chowbay B., Lim W.-T.
出版 2019

A phase 1 dose-finding and pharmacodynamic study of rapamycin in combination with bevacizumab in patients with unresectable hepatocellular carcinoma

由 Choo, S. P., Chowbay, B., Ng, Q. S., Thng, C. H., Lim, Cindy., Hartono, Septian., Koh, T. S., Huynh, H., Poon, D., Ang, M. K., Chang, S., Toh, H. C.
出版 2013

Keratin 15, transcobalamin I and homeobox gene Hox-B13 expression in breast phyllodes tumors: Novel markers in biological classification

由 Chong, L.Y.-Z., Cheok, P.Y., Tan, W.-J., Thike, A.A., Allen, G., Ang, M.K., Ooi, A.S., Tan, P., Teh, B.T., Tan, P.H.
出版 2014

Germline hemizygous deletion of CDKN2A-CDKN2B locus in a patient presenting with Li-Fraumeni syndrome

由 Chan, S.H, Lim, W.K, Michalski, S.T, Lim, J.Q, Ishak, N.D.B, Met-Domestici, M, Young, C.N.C, Vikstrom, K, Esplin, E.D, Fulbright, J, Ang, M.K, Wee, J, Sittampalam, K, Farid, M, Lincoln, S.E, Itahana, K, Abdullah, S, Teh, B.T, Ngeow, J
出版 2020

A three gene immunohistochemical panel serves as an adjunct to clinical staging of patients with head and neck cancer

由 Ong C.-A.J., Shannon N.B., Mueller S., Lek S.M., Qiu X., Chong F.T., Li K., Koh K.K.N., Tay G.C.A., Skanthakumar T., Hwang J.S.G., Lim T.K.H., Ang M.K., Tan D.S.W., Tan N.-C., Tan H.K., Soo K.C., Iyer N.G.
出版 2020

Molecular Subtypes in Head and Neck Cancer Exhibit Distinct Patterns of Chromosomal Gain and Loss of Canonical Cancer Genes

由 Walter V., Yin X., Wilkerson M.D., Cabanski C.R., Zhao N., Du Y., Ang M.K., Hayward M.C., Salazar A.H., Hoadley K.A., Fritchie K., Sailey C.G., Weissler M.C., Shockley W.W., Zanation A.M., Hackman T., Thorne L.B., Funkhouser W.D., Muldrew K.L., Olshan A.F., Randell S.H., Wright F.A., Shores C.G., Hayes D.N.
出版 2019

Impact of smoking and brain metastasis on outcomes of advanced EGFR mutation lung adenocarcinoma patients treated with first line epidermal growth factor receptor tyrosine kinase i...

由 Jain A., Lim C., Gan E.M., Ng D.Z., Ng Q.S., Ang M.K., Takano A., Chan K.S., Tan W.M., Kanesvaran R., Toh C.K., Loo C.M., Hsu A.A.L., Devanand A., Lim C.H., Koong H.N., Koh T., Fong K.W., Yap S.P., Kim S.W., Chowbay B., Oon L., Lim K.H., Lim W.T., Tan E.H., Tan D.S.W.
出版 2020

A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer

由 Ng, K.P., Hillmer, A.M., Chuah, C.T.H., Juan, W.C., Ko, T.K., Teo, A.S.M., Ariyaratne, P.N., Takahashi, N., Sawada, K., Fei, Y., Soh, S., Lee, W.H., Huang, J.W.J., Allen Jr., J.C., Woo, X.Y., Nagarajan, N., Kumar, V., Thalamuthu, A., Poh, W.T., Ang, A.L., Mya, H.T., How, G.F., Yang, L.Y., Koh, L.P., Chowbay, B., Chang, C.-T., Nadarajan, V.S., Chng, W.J., Than, H., Lim, L.C., Goh, Y.T., Zhang, S., Poh, D., Tan, P., Seet, J.-E., Ang, M.-K., Chau, N.-M., Ng, Q.-S., Tan, D.S.W., Soda, M., Isobe, K., Nöthen, M.M., Wong, T.Y., Shahab, A., Ruan, X., Cacheux-Rataboul, V., Sung, W.-K., Tan, E.H., Yatabe, Y., Mano, H., Soo, R.A., Chin, T.M., Lim, W.-T., Ruan, Y., Ong, S.T.
出版 2014